Johnson & Johnson Value Surges Past $630 Billion Ahead of New Financial Report

New Brunswick, Monday, 12 October 2026.
Johnson & Johnson’s market value has surged past $630 billion after a remarkable 41% annual stock gain, driven by strong cancer drug sales ahead of its quarterly earnings release.